Niklaus Schäfer

469 total citations
11 papers, 355 citations indexed

About

Niklaus Schäfer is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Niklaus Schäfer has authored 11 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Epidemiology. Recurrent topics in Niklaus Schäfer's work include Radiopharmaceutical Chemistry and Applications (3 papers), Neuroendocrine Tumor Research Advances (3 papers) and Prostate Cancer Treatment and Research (3 papers). Niklaus Schäfer is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (3 papers), Neuroendocrine Tumor Research Advances (3 papers) and Prostate Cancer Treatment and Research (3 papers). Niklaus Schäfer collaborates with scholars based in Switzerland, Germany and Chile. Niklaus Schäfer's co-authors include Michael Sommerauer, Guillaume Nicolas, Ivan Jambor, Anne Roivainen, Anass Johayem, Esa Kähkönen, Jörg‐Christian Tonn, Katharina Seystahl, Sandra Borkowski and Michael Weller and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Cancer Research.

In The Last Decade

Niklaus Schäfer

10 papers receiving 352 citations

Peers

Niklaus Schäfer
M. Soike United States
Samer E. Kaba United States
J. Curschmann Switzerland
Ralf Ketter Germany
Ilinca Popp Germany
Vipul T. Lakhani United States
Niklaus Schäfer
Citations per year, relative to Niklaus Schäfer Niklaus Schäfer (= 1×) peers Sreedharan Thankarajan Arunraj

Countries citing papers authored by Niklaus Schäfer

Since Specialization
Citations

This map shows the geographic impact of Niklaus Schäfer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niklaus Schäfer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niklaus Schäfer more than expected).

Fields of papers citing papers by Niklaus Schäfer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Niklaus Schäfer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niklaus Schäfer. The network helps show where Niklaus Schäfer may publish in the future.

Co-authorship network of co-authors of Niklaus Schäfer

This figure shows the co-authorship network connecting the top 25 collaborators of Niklaus Schäfer. A scholar is included among the top collaborators of Niklaus Schäfer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Niklaus Schäfer. Niklaus Schäfer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Neubauer, M., Guillaume Nicolas, Andreas Bauman, et al.. (2023). Early response monitoring during [177Lu]Lu-PSMA I&T therapy with quantitated SPECT/CT predicts overall survival of mCRPC patients: subgroup analysis of a Swiss-wide prospective registry study. European Journal of Nuclear Medicine and Molecular Imaging. 51(4). 1185–1193. 18 indexed citations
2.
Siebenhüner, Alexander, Melanie Langheinrich, Juliane Friemel, et al.. (2022). Orchestrating Treatment Modalities in Metastatic Pancreatic Neuroendocrine Tumors—Need for a Conductor. Cancers. 14(6). 1478–1478. 6 indexed citations
3.
Seystahl, Katharina, Veit M. Stoecklein, Ulrich Schüller, et al.. (2016). Somatostatin-receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to68Ga-DOTATATE/-TOC uptake. Neuro-Oncology. 18(11). now060–now060. 95 indexed citations
4.
Sommerauer, Michael, Niklaus Schäfer, Gerhard Huber, et al.. (2015). Sensitivity and Specificity of Dual-Isotope 99mTc-Tetrofosmin and 123I Sodium Iodide Single Photon Emission Computed Tomography (SPECT) in Hyperparathyroidism. PLoS ONE. 10(6). e0129194–e0129194. 8 indexed citations
5.
Seystahl, Katharina, Veit M. Stoecklein, Ulrich Schüller, et al.. (2015). MNGO-20SOMATOSTATIN RECEPTOR-TARGETED RADIONUCLIDE THERAPY FOR PROGRESSIVE MENINGIOMA. Neuro-Oncology. 17(suppl 5). v134.2–v134.
6.
Weber, Achim, Philipp Dutkowski, Niklaus Schäfer, et al.. (2013). Successful Salvage Chemotherapy with FOLFIRINOX for Recurrent Mixed Acinar Cell Carcinoma and Ductal Adenocarcinoma of the Pancreas in an Adolescent Patient. Case Reports in Oncology. 6(3). 497–503. 8 indexed citations
7.
Kähkönen, Esa, Ivan Jambor, Jukka Kemppainen, et al.. (2013). In Vivo Imaging of Prostate Cancer Using [68Ga]-Labeled Bombesin Analog BAY86-7548. Clinical Cancer Research. 19(19). 5434–5443. 162 indexed citations
8.
Boehmer, Lotta von, Peter K. Bode, Alexandro Landshammer, et al.. (2013). NY-ESO-1-specific immunological pressure and escape in a patient with metastatic melanoma. PubMed. 13. 12–12. 20 indexed citations
9.
Schäfer, Niklaus, Ray Valencia, Sandra Borkowski, et al.. (2011). Abstract 4139: Diagnostic performance of the F-18 labeled bombesin analog BAY 86-4367 in patients with primary prostate cancer. Cancer Research. 71(8_Supplement). 4139–4139. 1 indexed citations
10.
Boehmer, Lotta von, Wolfgang Jungraithmayr, İlhan İnci, et al.. (2011). Immunosuppression and lung cancer of donor origin after bilateral lung transplantation. Lung Cancer. 76(1). 118–122. 16 indexed citations
11.
Walton, Senta M., Marco Gerlinger, Olga de la Rosa, et al.. (2006). Spontaneous CD8 T Cell Responses against the Melanocyte Differentiation Antigen RAB38/NY-MEL-1 in Melanoma Patients. The Journal of Immunology. 177(11). 8212–8218. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026